NCT03852953View on ClinicalTrials.gov

Under- and Overdiagnosis in BreastScreen Norway

CompletedOBSERVATIONAL
Enrollment

3,915

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

June 8, 2020

Study Completion Date

June 8, 2020

Conditions
Breast Cancer
Interventions
OTHER

Under- or overdiagnosed cancer

Diagnosed with a cancer that was visible on prior mammograms

OTHER

Screening

Invited or attended BreastScreen Norway

Trial Locations (1)

0379

Cancer Registry of Norway, Oslo

All Listed Sponsors
collaborator

Extrastiftelsen

OTHER

lead

Norwegian Institute of Public Health

OTHER_GOV

NCT03852953 - Under- and Overdiagnosis in BreastScreen Norway | Biotech Hunter | Biotech Hunter